recombinant human galectin Search Results


recombinant human gal 9 protein  (R&D Systems)
94
R&D Systems recombinant human gal 9 protein
Recombinant Human Gal 9 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-9+Protein%2C+CF/pm36745103-39-24-28
Average 94 stars, based on 1 article reviews
recombinant human gal 9 protein - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
recombinant galectin  (R&D Systems)
93
R&D Systems recombinant galectin
Recombinant Galectin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-9+Protein%2C+CF/pm17907924-46-0-17
Average 93 stars, based on 1 article reviews
recombinant galectin - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
e coli  (R&D Systems)
94
R&D Systems e coli
E Coli, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-1+Protein/pmc09800892-71-5-10
Average 94 stars, based on 1 article reviews
e coli - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
recombinant human rh lgals3bp  (R&D Systems)
93
R&D Systems recombinant human rh lgals3bp
Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by <t>LGALS3BP.</t> a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-
Recombinant Human Rh Lgals3bp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-3BP%2FMAC-2BP+Protein%2C+CF/pm38066208-276-13-25
Average 93 stars, based on 1 article reviews
recombinant human rh lgals3bp - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
recombinant human gal  (R&D Systems)
92
R&D Systems recombinant human gal
Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by <t>LGALS3BP.</t> a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-
Recombinant Human Gal, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-7+Protein/pmc04437540-308-0-6
Average 92 stars, based on 1 article reviews
recombinant human gal - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
recombinant human galectin 3 binding protein  (R&D Systems)
94
R&D Systems recombinant human galectin 3 binding protein
Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by <t>LGALS3BP.</t> a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-
Recombinant Human Galectin 3 Binding Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-3+Protein/bio_rxiv__2023__12__20__572603-119-32-38
Average 94 stars, based on 1 article reviews
recombinant human galectin 3 binding protein - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
cf 9064 ga 050 r d systems recombinant human hmgb1 protein  (R&D Systems)
92
R&D Systems cf 9064 ga 050 r d systems recombinant human hmgb1 protein
Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by <t>LGALS3BP.</t> a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-
Cf 9064 Ga 050 R D Systems Recombinant Human Hmgb1 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-9+Protein%2C+CF/pmc11452643__41467_2024_52981_MOESM9_ESM-56-213-215
Average 92 stars, based on 1 article reviews
cf 9064 ga 050 r d systems recombinant human hmgb1 protein - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
gal 1  (R&D Systems)
90
R&D Systems gal 1
Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by <t>LGALS3BP.</t> a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-
Gal 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-1+Protein%2C+CF/10__1161_slash_atvbaha__111__240309-193-0-3
Average 90 stars, based on 1 article reviews
gal 1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human galectin 2  (Novus Biologicals)
90
Novus Biologicals human galectin 2
Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by <t>LGALS3BP.</t> a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-
Human Galectin 2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-2+His+Protein/pmc08541226-159-0-33
Average 90 stars, based on 1 article reviews
human galectin 2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
galectin 3c  (R&D Systems)
91
R&D Systems galectin 3c
Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by <t>LGALS3BP.</t> a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-
Galectin 3c, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-3C+Protein%2C+CF/pm36880731-320-52-54
Average 91 stars, based on 1 article reviews
galectin 3c - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
human galectin 8  (R&D Systems)
90
R&D Systems human galectin 8
Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by <t>LGALS3BP.</t> a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-
Human Galectin 8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Recombinant+Human+Galectin-8+Protein/pmc03398156-128-4-6
Average 90 stars, based on 1 article reviews
human galectin 8 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
lgals3myc ddk  (OriGene)
93
OriGene lgals3myc ddk
Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by <t>LGALS3BP.</t> a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-
Lgals3myc Ddk, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+galectin/Galectin+3+(LGALS3)+(NM_002306)+Human+Recombinant+Protein/us12466894-2308-3-19
Average 93 stars, based on 1 article reviews
lgals3myc ddk - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by LGALS3BP. a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-

Journal: Nature medicine

Article Title: Injury-specific factors in the cerebrospinal fluid regulate astrocyte plasticity in the human brain.

doi: 10.1038/s41591-023-02644-6

Figure Lengend Snippet: Fig. 5 | CSF-CCM promotes proliferation and NSC response in hiPS cell- derived astrocytes by LGALS3BP. a, Schematic timeline of experimental paradigm. b, Representative micrographs showing immunostainings for the astrocyte marker S100B and FGFR3 in hiAstros. c, Disease-specific CSF effects on EdU-incorporation in hiAstros cell cultures. White arrowheads indicate examples of EdU+ hiAstros. d, The percentage of EdU+ hiAstros in different culture conditions. e,f, Representative images of immunostaining for EdU, GFAP/S100B and GAL3 of hiAstros in control (e) or CSF-containing cultures (f). Filled white arrowheads indicate GAL3+EdU+ cells; empty white arrowheads depict Gal3+EdU− astrocytes. g, Representative micrographs showing reduced hiAstros proliferation after exposure either to LGALS3BP-function blocking antibody MDP1959 alone or in combination with CSF-CCM. h,i, Phase-contrast images of primary neurospheres generated from hiAstros in control or CSF-

Article Snippet: CSF-CCM or CSF-ICM (100 μl ml−1 medium), MDP1959 (40 μl ml−1 medium) and/or recombinant human (rh) LGALS3BP (10 μg ml−1 or 20 μg ml−1 medium; R&D Systems 2226-GAB) were added at the beginning of the experiment only.

Techniques: Derivative Assay, Marker, Immunostaining, Control, Blocking Assay, Generated